Orally active osteoanabolic agent GTDF binds to adiponectin receptors, with a preference for AdipoR1, induces adiponectin-associated signaling, and improves metabolic health in a rodent model of diabetes. [electronic resource]
Producer: 20141118Description: 3530-44 p. digitalISSN:- 1939-327X
- Adiponectin -- blood
- Animals
- Diabetes Mellitus, Type 2 -- drug therapy
- Disease Models, Animal
- Fatty Acids -- metabolism
- Glucose -- metabolism
- Insulin -- metabolism
- Insulin Resistance
- Lipid Metabolism -- drug effects
- Mice
- Muscle, Skeletal -- drug effects
- Obesity -- metabolism
- Quercetin -- analogs & derivatives
- Receptors, Adiponectin -- metabolism
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.